PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.28%
Positive revenue growth while 6247.T is negative. John Neff might see a notable competitive edge here.
14.06%
Gross profit growth at 50-75% of 6247.T's 23.34%. Martin Whitman would question if cost structure or brand is lagging.
2.39%
Positive EBIT growth while 6247.T is negative. John Neff might see a substantial edge in operational management.
41.30%
Operating income growth under 50% of 6247.T's 98.93%. Michael Burry would be concerned about deeper cost or sales issues.
-38.44%
Negative net income growth while 6247.T stands at 5.56%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-38.37%
Negative EPS growth while 6247.T is at 5.58%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-38.09%
Negative diluted EPS growth while 6247.T is at 5.45%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.03%
Share reduction while 6247.T is at 0.13%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.03%
Reduced diluted shares while 6247.T is at 0.27%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.73%
Negative 10Y revenue/share CAGR while 6247.T stands at 47.66%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-21.98%
Negative 5Y CAGR while 6247.T stands at 12.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-23.01%
Negative 3Y CAGR while 6247.T stands at 0.85%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.75%
Negative 10Y net income/share CAGR while 6247.T is at 247.94%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-70.48%
Negative 5Y net income/share CAGR while 6247.T is 28.20%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-81.25%
Negative 3Y CAGR while 6247.T is 46.21%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
268.61%
10Y equity/share CAGR above 1.5x 6247.T's 47.64%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
54.47%
5Y equity/share CAGR above 1.5x 6247.T's 19.25%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
21.53%
3Y equity/share CAGR above 1.5x 6247.T's 8.45%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.66%
AR growth well above 6247.T's 2.28%. Michael Burry fears inflated revenue or higher default risk in the near future.
-22.64%
Inventory is declining while 6247.T stands at 9.72%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.44%
Asset growth above 1.5x 6247.T's 1.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.60%
BV/share growth above 1.5x 6247.T's 0.41%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-33.71%
We’re deleveraging while 6247.T stands at 466.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
18.29%
R&D dropping or stable vs. 6247.T's 296.00%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
8.68%
SG&A growth well above 6247.T's 1.63%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.